CoChat

New Therapeutic Targets in Cardiology: Arrhythmias and Ca2+/Calmodulin-Dependent Kinase II (CaMKII)

Open access
Rokita, Adam G., Anderson, Mark E. · 2012 · Circulation
Cited by 108

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

C ardiac arrhythmias are a major epidemiological and public health problem and contribute significantly to sudden cardiac death, heart failure, stroke, suffering, debilitation, and healthcare expenses.In the United States alone, sudden cardiac death is estimated to kill 250 000 to 400 000 people annually.1 Most sudden death is due to cardiac arrhythmias, 2 with ventricular tachycardia and fibrillation as the most commonly (Ϸ80%) recorded rhythms in out-ofhospital cardiac arrests.3 In patients with structural heart disease, mostly resulting from a history of myocardial infarction, arrhythmias are the main cause of death.4 Atrial fibrillation (AF) and sinus node dysfunction (SND) are the most common sustained arrhythmias.AF affects Ϸ2.3 million patients in the United States, 5 and because the prevalence of AF increases with age, it is predicted to increase by 2.5-fold by 2050.6 Patients with AF have approximately twice the mortality rate of patients in sinus rhythm, 6 and the incidence of stroke is increased by 2-to 7-fold.7 AF is a costly disease and causes a public health burden estimated at $6.0 to $26.0 billion annually in the United States.8 SND is associated with increased sudden cardiac death, particularly in patients with heart failure, and a large portion (Ϸ40%) of mortality in hospitalized patients with heart failure may be secondary to SND. 9 SND is the indication for Ϸ60% of the 180 000 pacemakers implanted in the United States each year, a procedure that in 2004 accounted for Ϸ$2 billion in expenses.10,11 The negative impact of arrhythmias on human health and medical economics is a major motivating factor for establishing new and effective therapeutic approaches.Cardiac arrhythmias are the result of cell membrane hyperexcitability (the cause of automatic and triggered tachyarrhythmias), defective impulse formation (the cause of SND), or reduction in normal cell-to-cell electric coupling (the cause of conduction system "block" and a component of the zone of slow conduction in most arrhythmias supported by a reentrant circuit).Ion channels, macromolecular protein complexes with a cell membrane-spanning conductance pathway, are the fundamental units of membrane excitability, and rare congenital defects in ion channels or proarrhythmic off-target actions of many drugs can be sufficient to promote arrhythmia risk.However, most arrhythmias are not attributable to monogenic defects or drugs and occur in the biolog-ical context of various proarrhythmic factors such as advanced age, increased oxidant stress, ischemia, tissue injury, inflammation, and systemic disease (eg, hypertension, diabetes, heart failure).These proarrhythmic factors appear to favor structural remodeling of cardiac tissue and to predispose certain ion channels to initiate or sustain arrhythmias.Unfortunately, ion channel antagonist drugs have not proved to be broadly applicable, safe, or effective antiarrhythmic agents.12,13 Thus, a major goal for science and industry is to define molecular pathways and mechanisms that cause common and life-threatening arrhythmias to develop new and improved therapies.The multifunctional Ca 2ϩ /calmodulindependent protein kinase II (CaMKII) has emerged as a highly validated molecular mechanism with the potential to connect "upstream" proarrhythmic factors such as oxidation with "downstream" responses such as ion channel hyperactivity, defective intracellular Ca 2ϩ homeostasis, tissue damage, and scar formation that promote arrhythmias.Here, we review modern concepts of CaMKII molecular physiology in the context of fundamental arrhythmia mechanisms and consider evidence that CaMKII inhibition could be a broadspectrum antiarrhythmic strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.112.124990

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 108

Metadata

Authors
Rokita, A. G., & Anderson, M. E.
Venue
Circulation
Published
2012-10-23
Volume
126
Issue
17
Pages
2125-2139
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2133868014
Cited by
108
References
10
FWCI
7.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Therapeutic Targets in Cardiology: Arrhythmias and Ca2+/Calmodulin-Dependent Kinase II (CaMKII). https://app.cochat.ai/papers/10.1161/circulationaha.112.124990
The paper
Rokita, A. G., & Anderson, M. E. (2012). New Therapeutic Targets in Cardiology: Arrhythmias and Ca2+/Calmodulin-Dependent Kinase II (CaMKII). Circulation. https://doi.org/10.1161/circulationaha.112.124990

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.